stockrow
Friday 6 November 2026
Export DYN’s income statement to Excel — free account
Dyne Therapeutics, Inc.
- EPS
- −11.3%
- Free cash flow
- −39.1%
- Total debt
- +116.0%
Quarter to June 2026, against a year earlier
18.06
0.70
+4.03%
Follow DYN
Alert me
Dyne Therapeutics, Inc. (DYN) Book value per share
Dyne Therapeutics, Inc.'s book value per share at the end of fiscal 2025 was 7.6×, up 13.1% from 6.7× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 4.2×. Over the past ten years it has ranged from 0.1× (fiscal 2018) to 23.8× (fiscal 2020); the current reading is higher than 88% of that period. Dyne Therapeutics, Inc. ranks 170th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 7.6× | 13.13% |
| FY2024 | 6.7× | 337.38% |
| FY2023 | 1.5× | (68.50%) |
| FY2022 | 4.9× | (32.88%) |
| FY2021 | 7.2× | (69.58%) |
| FY2020 | 23.8× | 313.93% |
| FY2019 | 5.7× | 6,138.22% |
| FY2018 | 0.1× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 4.2× | (19.03%) |
| Mar 2026 | 5.2× | (30.75%) |
| Dec 2025 | 7.6× | 55.15% |
| Sep 2025 | 4.9× | (2.79%) |
| 24 more quarters | Free account |
Against its own ten years
Low 0.1×
High 23.8×
Ten-year median
6.2×
Current reading's percentile
88
Book value per share against peers
| Company | Book value per share |
|---|---|
| ELVN Enliven Therapeutics, Inc. compare | 13.5× |
| ACAD ACADIA Pharmaceuticals Inc. compare | 8.0× |
| VKTX Viking Therapeutics, Inc. compare | 5.0× |
| DNLI Denali Therapeutics Inc. compare | 4.9× |
| DYN Dyne Therapeutics, Inc. | 4.2× |
| TARS Tarsus Pharmaceuticals, Inc. compare | 2.2× |
| VRDN Viridian Therapeutics, Inc. compare | 0.0× |
| TLX Telix Pharmaceuticals Limited compare | 0.0× |
| CELC Celcuity, Inc. compare | −0.2× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))